Patent · US Active

Methods for treating rheumatoid arthritis with anti-bile salt-stimulated lipase (BSSL) antibodies

US8597650B2 · kind B2 · utility

1Cited by

0References

3Claims

0Family size

Inventors

Olle Hernell · Umeå, SE
Susanne Lindquist · Röbäck, SE
Lennart Gustav Lundberg · Lindome, SE

Key dates

Filing date	Apr 6, 2010
Grant date	Dec 3, 2013
Priority date	—
Expiry date	Apr 6, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

It provides methods and pharmaceutical compositions comprising antagonists to the protein Bile Salt-Stimulated Lipase (BSSL) for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. It further relates to pharmaceutical compositions comprising BSSL antagonists and their use in methods for the prevention, prophylaxis and treatment of inflammatory diseases, such as rheumatoid arthritis. Suitable BSSL antagonists to be used according to the invention are BSSL antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.